VWM
NVCR icon

Venturi Wealth Management’s NovoCure NVCR Stock Holding History

Venturi Wealth Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,266
Closed -$123K – 668
2026
Q1 		$123K Buy
+11,266
New +$141K 0.01% 594
2025
Q1 		– Sell
-2,319
Closed -$69.1K – 1411
2024
Q4 		$69.1K Sell
2,319
-1,350
-37% -$28.6K ﹤0.01% 920
2024
Q3 		$57.3K Buy
3,669
+1,354
+58% +$24.6K ﹤0.01% 722
2024
Q2 		$39.7K Buy
2,315
+2,121
+1,093% +$37.3K ﹤0.01% 736
2024
Q1 		$3.03K Buy
+194
New +$2.85K ﹤0.01% 1176

Other funds holding NVCR

BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
CMF
Counterpoint Mutual Funds San Diego, California $1.01B AUM 37.65% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Venturi Wealth Management's NVCR Position: Q2 2026 in Review

Venturi Wealth Management sold out of NovoCure (NVCR) in Q2 2026, closing a stake of 11,266 shares — an estimated $123K sold.

Venturi Wealth Management first reported a position in NVCR in Q1 2024 and held it in 5 quarters. The position peaked at $123K in Q1 2026. 19 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Venturi Wealth Management reported no remaining NovoCure position as of Q2 2026 after selling out during the quarter.
  • Venturi Wealth Management sold 11,266 NovoCure shares in Q2 2026, an estimated $123K.
  • Venturi Wealth Management first reported a position in NovoCure in Q1 2024 and held it in 5 quarters.
  • Venturi Wealth Management's NovoCure position peaked at $123K in Q1 2026.
  • 19 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.